[DPHARMA] QoQ Cumulative Quarter Result on 31-Dec-2014 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- 43.52%
YoY- 9.28%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 181,279 101,907 45,599 176,961 125,937 81,118 40,495 171.37%
PBT 32,226 20,605 12,198 46,509 32,589 21,302 11,175 102.46%
Tax -8,786 -5,788 -3,229 0 -8,014 -5,410 -2,810 113.67%
NP 23,440 14,817 8,969 46,509 24,575 15,892 8,365 98.63%
-
NP to SH 23,440 14,817 8,969 35,271 24,575 15,892 8,365 98.63%
-
Tax Rate 27.26% 28.09% 26.47% 0.00% 24.59% 25.40% 25.15% -
Total Cost 157,839 87,090 36,630 130,452 101,362 65,226 32,130 188.70%
-
Net Worth 268,509 190,284 205,045 192,942 187,436 179,045 190,050 25.88%
Dividend
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Div - 5,596 - 25,679 5,553 5,551 - -
Div Payout % - 37.77% - 72.81% 22.60% 34.93% - -
Equity
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Net Worth 268,509 190,284 205,045 192,942 187,436 179,045 190,050 25.88%
NOSH 278,959 139,915 139,486 138,807 138,841 138,794 138,723 59.24%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 12.93% 14.54% 19.67% 26.28% 19.51% 19.59% 20.66% -
ROE 8.73% 7.79% 4.37% 18.28% 13.11% 8.88% 4.40% -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 108.70 72.83 32.69 127.49 90.71 58.44 29.19 140.05%
EPS 14.04 10.59 6.43 25.41 17.70 11.45 6.03 75.58%
DPS 0.00 4.00 0.00 18.50 4.00 4.00 0.00 -
NAPS 1.61 1.36 1.47 1.39 1.35 1.29 1.37 11.35%
Adjusted Per Share Value based on latest NOSH - 138,813
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 18.85 10.59 4.74 18.40 13.09 8.43 4.21 171.40%
EPS 2.44 1.54 0.93 3.67 2.55 1.65 0.87 98.75%
DPS 0.00 0.58 0.00 2.67 0.58 0.58 0.00 -
NAPS 0.2791 0.1978 0.2132 0.2006 0.1949 0.1861 0.1976 25.86%
Price Multiplier on Financial Quarter End Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 -
Price 2.72 2.65 3.88 2.50 3.17 2.97 3.03 -
P/RPS 2.50 3.64 11.87 1.96 3.49 5.08 10.38 -61.25%
P/EPS 19.35 25.02 60.34 9.84 17.91 25.94 50.25 -47.03%
EY 5.17 4.00 1.66 10.16 5.58 3.86 1.99 88.87%
DY 0.00 1.51 0.00 7.40 1.26 1.35 0.00 -
P/NAPS 1.69 1.95 2.64 1.80 2.35 2.30 2.21 -16.36%
Price Multiplier on Announcement Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 24/11/15 25/08/15 18/05/15 24/02/15 21/11/14 26/08/14 20/05/14 -
Price 2.70 2.40 3.90 2.92 3.01 3.37 3.09 -
P/RPS 2.48 3.30 11.93 2.29 3.32 5.77 10.59 -61.97%
P/EPS 19.21 22.66 60.65 11.49 17.01 29.43 51.24 -47.97%
EY 5.21 4.41 1.65 8.70 5.88 3.40 1.95 92.43%
DY 0.00 1.67 0.00 6.34 1.33 1.19 0.00 -
P/NAPS 1.68 1.76 2.65 2.10 2.23 2.61 2.26 -17.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment